THE FISCAL YEAR May 1, 2011 – April 30, 2012
- Consolidated Net sales amounted to € 100 thousand (12) [1]
- Operating income amounted to € -7,363 thousand (-7,230)
- Net income after tax amounted to € -7,378 thousand (-7,411)
- Earnings per share amounted to € -0,13 (-0,17)
- Comprehensive income amounted to € -7,378 thousand (-7,411)
THE FOURTH QUARTER February 1 – April 30, 2012
- Consolidated Net sales amounted to € 0 thousand (0)
- Operating income amounted to € -2,182 thousand (-2,445)
- Net income after tax amounted to € -2,218 thousand (-2,417)
- Earnings per share amounted to € -0,04 (-0,05)
- Comprehensive income amounted to € -2,218 thousand (-2,417)
- Oasmia intends to complement the application for market approval with the EMA by performing a new smaller study.
EVENTS AFTER CLOSING DAY
- Oasmia and Orion jointly end Paccal® Vet agreement. Oasmia is finalizing an agreement with another party
- Nexttobe AB expands commitment to Oasmia through a MSEK 65 loan.